REGN - Regeneron Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 534.57B
Enterprise Value 334.53B
Trailing P/E 31.07
Forward P/E 115.23
PEG Ratio (5 yr expected) 11.48
Price/Sales (ttm)5.89
Price/Book (mrq)5.62
Enterprise Value/Revenue 35.88
Enterprise Value/EBITDA 615.52

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 20.41%
Operating Margin (ttm)35.41%

Management Effectiveness

Return on Assets (ttm)16.52%
Return on Equity (ttm)22.63%

Income Statement

Revenue (ttm)5.87B
Revenue Per Share (ttm)55.22
Quarterly Revenue Growth (yoy)29.00%
Gross Profit (ttm)5.48B
Net Income Avi to Common (ttm)1.2B
Diluted EPS (ttm)10.34
Quarterly Earnings Growth (yoy)-31.40%

Balance Sheet

Total Cash (mrq)1.41B
Total Cash Per Share (mrq)13.11
Total Debt (mrq)703.45M
Total Debt/Equity (mrq)11.45
Current Ratio (mrq)3.82
Book Value Per Share (mrq)57.14

Cash Flow Statement

Operating Cash Flow (ttm)1.31B
Levered Free Cash Flow (ttm)903.76M

Trading Information

Stock Price History

Beta 1.60
52-Week Change 3-14.59%
S&P500 52-Week Change 312.90%
52 Week High 3543.55
52 Week Low 3313.53
50-Day Moving Average 3331.92
200-Day Moving Average 3387.70

Share Statistics

Avg Vol (3 month) 3935.4k
Avg Vol (10 day) 3729.62k
Shares Outstanding 5105.68M
Float 79.46M
% Held by Insiders 125.06%
% Held by Institutions 169.44%
Shares Short 32.13M
Short Ratio 32.32
Short % of Float 32.79%
Shares Short (prior month) 31.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A